INVO BIOSCIENCE, INC.
5582 BROADCAST COURT
Sarasota, florida 32240
July 5, 2023
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Re: | INVO Bioscience, Inc. | |
| Registration Statement on Form S-1 | ||
| File No. 333-272872 |
Ladies and Gentlemen:
INVO Bioscience, Inc. (the “Company”) hereby requests, pursuant to Rule 461 under the Securities Act of 1933, as amended, that the effective date of the above-referenced registration statement be accelerated to 4:00 p.m., Eastern Time, on Friday July 7, 2023, or as soon thereafter as practicable.
| Very truly yours, | ||
| INVO BIOSCIENCE, INC. | ||
| By: | /s/ Steven Shum | |
| Steven Shum | ||
| Chief Executive Officer | ||